Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MDxHealth (MDXH)
NASDAQ:MDXH
Holding MDXH?
Track your performance easily
MDXH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.55 - $4.44
Previous CloseN/A
Volume27.23K
Average Volume (3M)131.26K
Market Cap
$98.99M
Enterprise Value$64.25M
Total Cash (Recent Filing)$30.87M
Total Debt (Recent Filing)$108.00K
Price to Earnings (P/E)―
Beta-1841.40
Next Earnings
Feb 26, 2025EPS Estimate
-0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.53
Shares Outstanding49,497,334
10 Day Avg. Volume167,557
30 Day Avg. Volume131,259
Standard Deviation0.14
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.81
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue5.76
Enterprise Value/Gross Profit1.46
Enterprise Value/Ebitda-6.08
Forecast
1Y Price Target
$6.50Price Target Upside240.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
MDxHealth News
Ownership Overview
―
Insiders
0.08%
Mutual Funds
45.90% Other Institutional Investors
54.02% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MDXH FAQ
What was MDxHealth’s price range in the past 12 months?
MDxHealth lowest stock price was $1.55 and its highest was $4.44 in the past 12 months.
What is MDxHealth’s market cap?
MDxHealth’s market cap is $98.99M.
When is MDxHealth’s upcoming earnings report date?
MDxHealth’s upcoming earnings report date is Feb 26, 2025 which is in 26 days.
How were MDxHealth’s earnings last quarter?
MDxHealth released its earnings results on Nov 06, 2024. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.27 by -$0.13.
Is MDxHealth overvalued?
According to Wall Street analysts MDxHealth’s price is currently Undervalued.
Does MDxHealth pay dividends?
MDxHealth does not currently pay dividends.
What is MDxHealth’s EPS estimate?
MDxHealth’s EPS estimate is -0.19.
How many shares outstanding does MDxHealth have?
MDxHealth has 49,497,334 shares outstanding.
What happened to MDxHealth’s price movement after its last earnings report?
MDxHealth reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.27. Following the earnings report the stock price went up 0.481%.
Which hedge fund is a major shareholder of MDxHealth?
Currently, no hedge funds are holding shares in MDXH
---
MDxHealth Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.50 (240.31% Upside)
$6.50 (240.31% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.91%
12-Months-Change
Fundamentals
Return on Equity
-240.82%
Trailing 12-Months
Asset Growth
15.97%
Trailing 12-Months
Company Description
MDxHealth
MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. It offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
---
MDXH Company Deck
---
MDXH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, increased test volumes, and a successful capital raise, which led to an increase in revenue guidance. However, there was a noted decline in gross margins and an increase in operating loss. Overall, the positive aspects, particularly the substantial revenue growth and raised guidance, outweighed the lowlights.Read More>---
MDXH Stock 12 Month Forecast
Average Price Target
$6.50
▲(240.31% Upside)
Technical Analysis
Best Analysts Covering MDXH
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-21.10%
assigned a buy rating 18 days ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -21.10% per trade.
---